Trexquant Investment’s Immunovant IMVT Stock Holding History

Trexquant Investment’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Buy	79,920 +54,228	+211%	+$1.65M	0.02%	987
2026 Q1	$638K	Sell	25,692 -89,303	-78%	-$2.31M	﹤0.01%	1385
2025 Q4	$2.92M	Buy	+114,995	New	+$2.56M	0.03%	833
2024 Q2	–	Sell	-58,218	Closed	-$1.88M	–	1674
2024 Q1	$1.88M	Buy	+58,218	New	+$2.12M	0.04%	682
2023 Q4	–	Sell	-77,806	Closed	-$2.99M	–	1592
2023 Q3	$2.99M	Buy	+77,806	New	+$1.76M	0.07%	367
2023 Q2	–	Sell	-34,184	Closed	-$530K	–	1594
2023 Q1	$530K	Sell	34,184 -43,208	-56%	-$750K	0.01%	975
2022 Q4	$1.37M	Buy	+77,392	New	+$974K	0.04%	534
2021 Q4	–	Sell	-18,198	Closed	-$158K	–	1444
2021 Q3	$158K	Buy	+18,198	New	+$164K	0.01%	999

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Trexquant Investment's IMVT Position: Q2 2026 in Review

Trexquant Investment increased its Immunovant (IMVT) stake by 211% in Q2 2026, buying an estimated $1.65M and bringing the position to 79,920 shares worth $3.08M. The position accounts for 0.02% of the portfolio, ranked #987.

Trexquant Investment first reported a position in IMVT in Q3 2021 and has held it in 8 quarters since. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Trexquant Investment held 79,920 shares of Immunovant worth $3.08M as of Q2 2026.
Trexquant Investment bought 54,228 Immunovant shares in Q2 2026, an estimated $1.65M.
Immunovant made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #987 holding.
Trexquant Investment first reported a position in Immunovant in Q3 2021 and has held it in 8 quarters since.
227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.